Both Ozempic and Mounjaro are approved by the FDA to treat Type 2 diabetes, but some doctors prescribe the medication "off-label" for weight loss, as is permissible by the FDA.
Today, Pactiv Evergreen Inc. introduces an innovative packaging solution with the launch of its patented* SmartPour™ package. Made in the USA, SmartPour packaging features an easy-to-pour and ...